IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies. It is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations; for enhancing immunotherapy response and immuno-oncology therapies targeting the tumour microenvironment.
|HQ||South San Francisco, CA, US||Map|
Revenue (Q1, 2021)
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (4-Jun-2021)
Closing stock price (4-Jun-2021)
|USD||Q1, 2018||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q1, 2021|
Depreciation and Amortization
Cash From Operating Activities
When was IDEAYA Biosciences founded?
IDEAYA Biosciences was founded in 2015.
Who are IDEAYA Biosciences key executives?
IDEAYA Biosciences's key executives are Michael P. Dillon, Timothy Shannon and Yujiro S. Hata.
How many employees does IDEAYA Biosciences have?
IDEAYA Biosciences has 56 employees.
What is IDEAYA Biosciences revenue?
Latest IDEAYA Biosciences annual revenue is $19.5 m.
What is IDEAYA Biosciences revenue per employee?
Latest IDEAYA Biosciences revenue per employee is $348.9 k.
Who are IDEAYA Biosciences competitors?
Competitors of IDEAYA Biosciences include Jiangsu Hansoh Pharmaceutical Group, 3sbio and Ethypharm.
Where is IDEAYA Biosciences headquarters?
IDEAYA Biosciences headquarters is located at 7000 Shoreline Ct #350, South San Francisco.
Where are IDEAYA Biosciences offices?
IDEAYA Biosciences has offices in South San Francisco and San Diego.
How many offices does IDEAYA Biosciences have?
IDEAYA Biosciences has 2 offices.
Receive alerts for 300+ data fields across thousands of companies